All News

The FDA assigned a Prescription Drug User Fee Action date is January 31, 2025.

Presentations highlighted the potential of tarlatamab in treating solid tumor cancers.

Breanne Peyton-Thomas, PharmD, BCOP, discusses her work as a pharmacist at Ochsner Health on the CAR T-cell therapy team.

Pharmacy students develop concept for exam augmented reality glasses for clinical situations and patient counsling.

Complex projects require the engagement of multiple stakeholders.

Blaming community pharmacies and community pharmacists for a lack of expedited practice evolution is naive at best, and disingenuous or outright malicious at worst.

Lalan Wilfong, MD, discusses the road to value-based care and payment reform in cancer care.

Despite the new human case, which is not known to be related to animal exposure, the CDC emphasizes that risk to the general public remains low.

Datopotamab deruxtecan was effective in patients with TROP2-QCS biomarker-positive tumors for non–small cell lung cancer

Lazertinib with amivantamab was found to be similar in efficacy to osimertinib in the MARIPOSA study.

Experts debate over the most effective treatment pathway for Richter transformation, highlighting the risks and benefits of different cellular therapies.

MJH Life Sciences is celebrating its 25th anniversary.

The study authors suggest that annual screening for women aged 40 and older may be beneficial, but warn of the increased risk of false positive results.

Pharmacists are encouraged to leverage their trusted community role to help manage the anticipated health care burden from respiratory infections this season.

Treatment advancements highlight the curative potential of bone marrow transplants and emerging gene therapies.

Alessandra Ferrajoli, MD, discusses the importance of renal function for BCL2 inhibitors to avoid tumor lysis syndrome and cardiovascular history for BTK inhibitors to mitigate arrhythmia risks.

Individuals with a history of shingles was significantly and independently connected with a 20% higher risk of for subjective cognitive decline.

Full traditional approval follows accelerated approval of the medication last year.

The evolving treatment landscape for multiple myeloma includes debates on the timing and effectiveness of CAR T-cell therapy and quadruple immunotherapy regimens.

Edaravone and dexborneol sublingual tablets are an innovative first drug to be designed for treatment of stroke and granted this designation.

RSV vaccination was 75% effective in preventing RSV-associated hospitalizations among adults aged 60 years and older.

Reid Merryman, MD, discusses the potential for minimal residual disease (MRD) to inform treatment decisions, identify lymphoma subgroups, and infer gene expression.

Disease-related factors include several prognostic scoring systems, such as DIPSS, whereas patient-related factors involve age, comorbidities, spleen size, and anemia.

New transparency initiatives will go into effect on January 1, 2025, building off previous actions by the Centers of Medicare and Medicaid Services.

A pharmacist with Allegheny Health Network discusses travel vaccines and what resources are valuable when determining which vaccinations are needed prior to travel.

ALZ-801 has now progressed to the phase 3 APOLLOE4 study, designed to evaluate efficacy, safety, and biomarker and imaging effects.

Pharmacy professors discuss their experience implementing a TikTok activity in their curriculum, highlighting the benefits and challenges.